Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseNDA/BLA |
First Approval Ctry. / Loc.- |
First Approval Date- |
Double-blind, Vehicle-controlled, Randomised, Multi-centre Study to Evaluate the Efficacy and Safety of LH-8 Cutaneous Solution in Children and Adolescents With Moderate to Severe Scalp Alopecia Areata.
Double-blind, randomised, multi-centre study to evaluate the efficacy and safety of LH-8 cutaneous solution versus placebo in children and adolescents with moderate to severe scalp alopecia areata.
Phase 2/3 study performed in France, Germany, Bulgaria and India in 100 patients.
A Randomized, Double Blind, Single Center, Controlled Study to Compare the Efficacy, Safety and Tolerability of CG 428 Cutaneous Solution With Placebo on Alopecia in Cancer Female Patients Under Chemotherapy
100 Clinical Results associated with Legacy Healthcare (Switzerland) SA
0 Patents (Medical) associated with Legacy Healthcare (Switzerland) SA
01 Mar 2021·Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]Q3 · MEDICINE
Hair Transplantation in Endocrine Therapy–Induced Alopecia
Q3 · MEDICINE
Article
Author: Guichard, Alexandre ; Bouhanna, Pierre ; Larif, Molka
100 Deals associated with Legacy Healthcare (Switzerland) SA
100 Translational Medicine associated with Legacy Healthcare (Switzerland) SA